• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Integrative pharmacogenomic analysis of patient-derived xenografts of Chinese hepatocellular carcino

Integrative pharmacogenomic analysis of patient-derived xenografts of Chinese hepatocellular carcino

来源 :2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 | 被引量 : 0次 | 上传用户：cxwycn
【摘 要】
：
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.Patient derived xenografts (PDX),generated by direct engraftment of tumor
【作 者】
：
Hu Gang Weikang Tao He Zhou Huang Yong Yujian Shi Xueyan Yang Hui Zhou Haisong Lu Limei Ouyang Xiaolong Zhu Zhuolin Gong 
【机 构】
：
ClinicalExplorer (Shanghai) Co.,Ltd.Shanghai,China;Shanghai Chempartner Co.,Ltd.Shanghai,China
【出 处】
：
2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.Patient derived xenografts (PDX),generated by direct engraftment of tumor samples from the patients into immunocompromised mice can be used as an in vivo platform that provides the opportunity to test personalized medicine strategies.
其他文献
DC120, a novel AKT inhibitor, preferentially inhibits nasopharyngeal carcinoma cancer stem-like cell
Side population (SP) cells in human nasopharyngeal carcinoma (NPC) are known to be enriched for cancer stem-like cells (CSLCs) and are the main cause of drug-resistance and tumor metastasis.In this st
会议
Inhibition of DNA Methyltransferase as a Novel Therapeutic Strategy to Overcome Acquired Resistance
Dual PI3K/mTOR(phosphatidylinositol 3-kinase/mammalian target of rapamycin) inhibitors are being evaluated clinically for the treatment of tumors with a hyperactivated PI3K/mTOR pathway.However, unexp
会议
Ubiquitin degradation of ULK1 by ERK1 and GSK-3β cooperatively attenuates mitophagy and promotes tum
The modulation of autophagy is an important component of tumor initiation and progression and ULK1 plays an essential role in macroautophagy and mitophagy.However, the precise regulatory signaling mec
会议
The role and mechanism of HM910 in cell proliferation on multiple myeloma
Objective: To explore the role and mechanism of HM910 in cell proliferation on multiple myeloma.Methods: Human multiple myeloma cell lines RPMI-8226, OPM-2, NCI-H929 and U266 were used to perform an M
会议
NCI-H929HM910CDK4Cell CycleApoptosis
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10
Objective: Linsitinib, a novel dual insulin-like growth factor 1 (IGF-1R)/insulin receptor (IR) kinase inhibitor in phase Ⅲ clinical trial, was investigated the reversal of multidrug resistance (MDR)
会议
LinsitinibMulti-drug resistanceABC transportersABCG2ABCC10
Cancer cells were transiently protected from chemotherapeutical agent via emergency intercellular tr
Background: Multidrug resistance (MDR) is a major impediment to the overall success of chemotherapy in clinical oncology.Recently, the intercellular transfer of ABCB1 between tumor cells has been prop
会议
ABCB1intercellular transferchemotherapeutic drugsMDR
Elevated Expression of Plasma Membrane Ca2+ channel Orai1 and Intracellular Ca2+ Oscillations Contri
Objective: Largely due to the fact that most of patients suffering from ESCC are diagnosed at advanced states, the 5-year survival rate is merely 19%, which is the fourth worst among all cancers.Thus,
会议
ESCCOrai1STIM1SOCEintracellular Ca2+oscillationscell proliferationmigratio
Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-li
Cancer stem-like cells (CSC) have garnered significant attention as a therapeutic focus, based on evidence they may represent an etiologic root of treatment-resistant cells.Indeed, expression of the m
会议
Cancer stem cellsABCG2AfatinibPromoter methylationCombination chemotherapy
Lapatinib antagonizes multidrug resistance-associated protein 1 mediated multidrug resistance by inh
Lapatinib, a tyrosine kinase inhibitor (TKI), is used in the treatment of advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2).Lapatinib can modulate the function of A
会议
ABC transportersMRP1LRPAKTERK1/2
肺癌患者的癌因性疲乏与化疗不良反应的相关性
会议
肺癌癌因性疲乏化疗后相关不良反应相关性